151 related articles for article (PubMed ID: 1537076)
1. Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.
Musch E; Malek M; Peter-Katalinic J; Egge H; Rink H; Lathan B; Riedel E
Cancer Chemother Pharmacol; 1992; 29(4):297-304. PubMed ID: 1537076
[TBL] [Abstract][Full Text] [Related]
2. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay.
Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B
Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration.
Loos U; Musch E; Malek M; Riedel E
Oncology; 1991; 48(4):334-42. PubMed ID: 1891177
[TBL] [Abstract][Full Text] [Related]
4. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients.
Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H
Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and cell-biological investigation of prednimustine compared to its components chlorambucil and prednisolone.
Musch E; Loos U; Alléra A; Hügl E; Pütz I; Malek M
J Chemother; 1989 Jul; 1(4 Suppl):1127-9. PubMed ID: 16312803
[No Abstract] [Full Text] [Related]
6. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue.
Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI
J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719
[No Abstract] [Full Text] [Related]
7. Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisolone, and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Semin Oncol; 1986 Mar; 13(1 Suppl 1):8-13. PubMed ID: 3952521
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of prednimustine and chlorambucil in the rat.
Newell DR; Shepherd CR; Harrap KR
Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268
[TBL] [Abstract][Full Text] [Related]
9. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats.
Berger MR; Habs M; Schmähl D
Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line.
Hartley-Asp B; Gunnarsson PO; Liljekvist J
Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307
[TBL] [Abstract][Full Text] [Related]
11. Nitrogen mustard-DNA interaction in melphalan-resistant mammary carcinoma cells with elevated intracellular glutathione and glutathione-S-transferase activity.
Alaoui-Jamali MA; Panasci L; Centurioni GM; Schecter R; Lehnert S; Batist G
Cancer Chemother Pharmacol; 1992; 30(5):341-7. PubMed ID: 1505071
[TBL] [Abstract][Full Text] [Related]
12. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
Sharma P; Ganta S; Denny WA; Garg S
Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
[TBL] [Abstract][Full Text] [Related]
13. Chlorambucil pharmacokinetics and DNA binding in chronic lymphocytic leukemia lymphocytes.
Bank BB; Kanganis D; Liebes LF; Silber R
Cancer Res; 1989 Feb; 49(3):554-9. PubMed ID: 2910477
[TBL] [Abstract][Full Text] [Related]
14. Studies on the pharmacokinetics of chlorambucil and prednimustine in man.
Newell DR; Calvert AH; Harrap KR; McElwain TJ
Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759
[TBL] [Abstract][Full Text] [Related]
15. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
[TBL] [Abstract][Full Text] [Related]
16. Mammary tumour inhibition and subacute toxicity in rats of prednimustine and of its molecular components chlorambucil and prednisolone.
Fredholm B; Gunnarsson K; Jensen G; Müntzing J
Acta Pharmacol Toxicol (Copenh); 1978 Mar; 42(3):159-63. PubMed ID: 580343
[TBL] [Abstract][Full Text] [Related]
17. The antitumor effect of prednimustine in vitro and in vivo.
Hartley-Asp B
Semin Oncol; 1986 Mar; 13(1 Suppl 1):3-7. PubMed ID: 3952519
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein.
Endresen L
Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone.
Ideström K; Kimby E; Björkholm M; Mellstedt H; Engstedt L; Gahrton G; Johansson B; Killander D; Robérts KH; Stalfelt AM; Udén AM; Wadman B; Wählby S
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1117-23. PubMed ID: 6897633
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).
Ehrsson H; Wallin I; Nilsson SO; Johansson B
Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
